Phase-250 Injection

Hydroxyprogesterone Caproate 250 mg Injection — Preterm Prevention

Phase-250 Injection — Hydroxyprogesterone Caproate 250 mg from Trumac Healthcare PCD Pharma Franchise India

Composition Hydroxyprogesterone Caproate 250 mg
Dosage Form Injection (Ampoule)
Pack Type Glass Ampoule
Pack Size 1 ml Ampoule
MRP ₹ 126.5
Therapy Gynaecology / Obstetrics — Long-Acting Progestogen
Storage Store below 25 °C, protect from light.

📱 WhatsApp Enquiry📞 Call: +919041677932

About Phase-250 Injection

Phase-250 Injection provides Hydroxyprogesterone Caproate 250 mg IM — the standard weekly dose for preterm birth prevention in women with prior spontaneous preterm singleton delivery. Per ACOG/FOGSI guidelines.

Manufactured by Trumac Healthcare under WHO-GMP. Available for monopoly-based PCD pharma franchise and third-party manufacturing.

Indications

  • Preterm birth prevention (prior PTD history)
  • Habitual abortion
  • Threatened miscarriage with low progesterone
  • DUB management

Mechanism of Action

Hydroxyprogesterone Caproate is a long-acting progestin (synthetic 17α-hydroxyprogesterone derivative) — binds progesterone receptors in endometrium and uterine smooth muscle. Used to prevent preterm birth in women with prior preterm singleton delivery (per ACOG, FOGSI guidelines). Also used in DUB and habitual abortion.

Dosage & Administration

Pregnancy: 250 mg IM weekly from 16–20 weeks until 36 weeks gestation.

Side Effects

Injection site reactions (most common), nausea, headache, breast tenderness, fluid retention. VTE risk theoretical but not significantly increased.

Contraindications & Precautions

Pregnancy with severe gestational diabetes, history of VTE, hormone-sensitive cancers, severe hepatic disease.

Storage

Store below 25 °C, protect from light.

PCD Pharma Franchise & Third-Party Manufacturing
Phase-250 Injection is available for monopoly-based PCD pharma franchise across India and for third-party manufacturing under your brand. WHO-GMP certified, with full visual-aid and promotional support. Become a Trumac franchise partner →

Frequently Asked Questions

What is Phase-250 Injection used for?

Phase-250 Injection contains Hydroxyprogesterone Caproate 250 mg. Used as per the indications described above.

How should Phase-250 Injection be taken?

As directed by your physician. Complete the prescribed course.

Is Phase-250 Injection available for PCD pharma franchise?

Yes, Trumac Healthcare offers Phase-250 Injection on monopoly-based PCD pharma franchise and for third-party manufacturing.

How should Phase-250 Injection be stored?

Store below 30 °C in a dry place, protected from light and moisture.

Is Phase-250 Injection WHO-GMP certified?

Yes, manufactured in WHO-GMP and DCGI-compliant facilities.

Related Products

B2B Disclaimer: This page is part of a Business-to-Business (B2B) pharmaceutical catalog intended for distributors, PCD franchise partners and healthcare professionals. Information provided is for commercial and educational reference only. Not for consumer sale. Patients must not self-medicate; please consult a qualified medical practitioner. All trade inquiries are subject to valid Drug License and GST documentation.